查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985758

疝氣修補市場：依產品類型、手術方法、疝氣類型和最終用戶分類－2026-2032年全球市場預測

Hernia Repair Market by Product Type, Procedure Type, Hernia Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，疝氣修補市場價值將達到 50.4 億美元，到 2026 年將成長至 53.1 億美元，到 2032 年將達到 73.1 億美元，複合年成長率為 5.45%。

主要市場統計數據
基準年 2025 50.4億美元
預計年份：2026年 53.1億美元
預測年份 2032 73.1億美元
複合年成長率 (%) 5.45%

這篇前瞻性的介紹總結了外部技術的進步、材料的創新以及醫療保健服務模式的變化如何重塑臨床實踐和供應商的策略。

疝氣修補手術在外科創新、材料科學和不斷變化的醫療服務模式的交匯點上不斷發展。本執行摘要整合了影響該領域的當代促進因素，重點介紹了供應商和醫療服務提供者面臨的關鍵轉折點，並闡述了對整個醫療流程中的相關人員有重大影響的機會。

對疝氣修補術中技術、程序和監管變革的融合進行分析性回顧，這些變革正在重新定義產品要求和臨床引入途徑。

疝氣修補領域正經歷一場變革，其驅動力來自技術進步、政策轉變以及不斷變化的臨床需求。生物材料和合成支架的進步催生了新一代植入，這些植入物強調生物相容性、個人化分解特性以及表面工程，從而降低感染和沾黏的風險。這些材料創新並非孤立存在，而是與手術趨勢相互作用，尤其是微創技術的廣泛應用，重塑了產品需求和性能標準。

對 2025 年預期關稅變化將如何影響疝氣修復相關人員的採購、供應鏈韌性和策略採購進行全面評估。

美國預計2025年進行的關稅調整將為疝氣修補器材的籌資策略和全球供應鏈規劃帶來新的複雜性。關稅趨勢可能會影響進口原料和成品植入的成本結構，進而影響採購決策、庫存策略和商業定價。與跨境供應商建立合作關係的企業需要重新審視合約條款、物流路線和關稅減免策略，以保持競爭力。

基於詳細的細分觀點，將材料分類、手術亞型、解剖適應症和臨床環境聯繫起來，制定個人化的臨床和商業策略。

基於細分市場的洞察對於理解個人產品特性、手術方法、疝氣類型和醫療環境如何相互交織，進而影響臨床決策和商業策略至關重要。在考慮產品類型時，分析必須區分生物網膜和合成網片。生物網膜片又可再細分為動物源性和人源性結構，而合成網片則包括聚酯、聚丙烯和聚四氟乙烯等不同材質，每種材質都有獨特的操作性、組織整合性和抗感染性。這些材料差異會影響外科醫師的選擇偏好、消毒通訊協定以及對術後管理的預期。

透過精細的區域分析，指導市場進入和業務擴張計劃，協調美洲、歐洲、中東和非洲以及亞太地區不同臨床實踐、管理體制和供應鏈的實際情況。

區域趨勢對臨床實踐模式、監管預期和供應鏈結構產生顯著影響，從而在不同地區形成獨特的策略考量。在美洲，大規模學術醫療中心和不斷擴展的門診手術中心網路對醫療服務至關重要，這些因素共同推動了對兼具卓越臨床性能和高效運作的醫療設備的需求。報銷模式以及公共和私人保險公司的組成也影響著採購重點和證據要求。

透過策略整合競爭因素、創新重點領域和夥伴關係模式，重新定義疝氣修補市場的差異化和價值創造。

疝氣修補領域的競爭動態反映了傳統外科醫療設備領導企業與生物材料和固定技術領域新興創新者之間的平衡。大型企業持續投資於聚合物和生物基支架的迭代改進、微創手術的先進輸送系統，並致力於提供證據以支持基於價值的採購策略。同時，小規模的專業公司則專注於突破性的材料化學、表面改質以及抗菌塗層和可吸收固定裝置等添加劑技術。

為疝氣修復領域的領導者提供切實可行的建議，使研發、供應鏈和商業模式與臨床結果和支付方期望保持一致。

產業領導者可以透過將研發、商業和營運重點與臨床和支付方的需求相結合，採取果斷行動，將新興趨勢轉化為永續優勢。首先，他們應優先投資於能夠顯著改善與醫療機構整合、降低感染風險並簡化開放式和腹腔鏡手術移植流程的材料和輸送系統，並以可操作的臨床終點和真實世界數據收集工作為支撐。其次，他們應制定跨部門的循證藍圖，納入外科醫生主導的註冊登記和上市後監測，以滿足監管機構和購買方的需求，同時縮短產品迭代改進的反饋週期。

為了檢驗結論和建議，我們採用了一種透明的混合方法研究設計，結合了臨床醫生的見解、監管和臨床文獻綜述以及供應鏈情境分析。

為支持這份執行報告，研究系統性地整合了多種一手和二手資訊收集方法，旨在確保分析的嚴謹性和實用性。一手資訊包括對一般外科和微創外科臨床專家、門診、診所和醫院的採購經理以及生物材料和監管事務專家進行的結構化訪談。這些定性討論有助於提出假設，並幫助確定需要進一步深入分析的優先領域。

一份權威的綜合報告，強調了將臨床證據、營運韌性和個人化商業化相結合以改善結果和提供永續價值的必要性。

總而言之，疝氣修補領域正處於一個轉折點，其驅動力來自材料創新、微創技術的進步以及受區域環境和貿易政策變化影響的採購趨勢轉變。在臨床差異化和營運效率同等重要的競爭環境中，將嚴謹的臨床證據產生與切實可行的供應鏈和商業化策略相結合的相關人員將獲得策略優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 疝氣修補市場：依產品類型分類

  • 生物網膜
    • 動物源性
    • 人類
  • 複合網格
    • 聚酯纖維
    • 聚丙烯
    • 聚四氟乙烯

第9章 疝氣修補術市場（依手術方法分類）

  • 腹腔鏡
    • 完全腹膜外法
    • 經腹膜前入路
  • 開放性手術

第10章：疝氣修補市場（依疝氣類型分類）

  • 食道裂孔疝
  • 切口疝
  • 鼠蹊部
  • 臍疝氣
  • 腹壁疝

第11章 疝氣修補市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章 疝氣修補市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 疝氣修補市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 疝氣修補市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國疝氣修補市場

第16章：中國疝氣修補市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AbbVie Inc.
  • Aran Biomedical by Integer Holdings Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast A/S
  • CooperSurgical, Inc.
  • Cousin Surgery
  • Deep Blue Medical Advances, Inc.
  • Dolphin Sutures
  • Getinge AB
  • HERNIAMESH Srl
  • Hwainmedi Co., Ltd.
  • Insightra Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KATSAN Katgut Sanayi ve Tic. AS
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Momentis Surgical Ltd.
  • Novus Scientific AB
  • Olympus Corporation
  • Secant Group, LLC
  • Surgimatix, Inc.
  • TELA Bio, Inc.
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-351BAD5033FF

The Hernia Repair Market was valued at USD 5.04 billion in 2025 and is projected to grow to USD 5.31 billion in 2026, with a CAGR of 5.45%, reaching USD 7.31 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.04 billion
Estimated Year [2026] USD 5.31 billion
Forecast Year [2032] USD 7.31 billion
CAGR (%) 5.45%

A forward-looking introduction synthesizing surgical evolution, material innovation, and care model shifts that are reshaping clinical practice and supplier strategies

Hernia repair continues to evolve at the intersection of surgical innovation, material science, and shifting care delivery models. This executive summary synthesizes contemporary drivers shaping the field, highlights inflection points for suppliers and providers, and frames high-impact opportunities for stakeholders across the care continuum.

Clinical practice now emphasizes outcomes beyond simple recurrence metrics, with tissue integration, infection resistance, and patient-reported recovery experience gaining prominence. Concurrently, device manufacturers are refining material formulations and scaffold architectures to address both acute and chronic repair needs, while health systems press for procedures that reduce length of stay and readmission risk. As minimally invasive approaches expand, perioperative pathways and device compatibility with laparoscopic techniques are increasingly decisive factors for procurement and adoption.

Regulatory scrutiny and payer engagement continue to influence product development strategies and evidence generation priorities, prompting manufacturers to integrate real-world data and comparative-effectiveness endpoints into their clinical programs. Moreover, cross-disciplinary collaboration among surgeons, materials scientists, and regulatory experts is accelerating translational steps from bench innovations to bedside adoption. The following sections unpack these dynamics and offer pragmatic insights for leaders navigating this complex landscape.

An analytical review of converging technological, procedural, and regulatory shifts that are redefining product requirements and clinical adoption pathways in hernia repair

The hernia repair landscape is undergoing transformative shifts driven by converging technological advances, policy changes, and evolving clinical expectations. Advances in biomaterials and synthetic scaffolds are enabling next-generation implants that emphasize biocompatibility, tailored degradation profiles, and surface engineering to mitigate infection and adhesion risks. These material innovations are not isolated; they interact with procedural trends-particularly the broader adoption of minimally invasive techniques-to reshape product requirements and performance benchmarks.

Parallel to technological progress, healthcare delivery models are moving care episodes from inpatient wards to ambulatory settings wherever clinically appropriate, prompting product design considerations for ease of use, sterility assurance, and the facilitation of shorter recovery pathways. Regulatory pathways are also adapting, with authorities increasingly requiring robust clinical endpoints and post-market surveillance strategies, which in turn drive manufacturers to invest in longer-term outcome studies and real-world evidence systems.

Collectively, these factors create a higher bar for clinical differentiation while opening opportunities for companies that align device features with workflow efficiencies and evidence generation. Payers and hospitals are simultaneously rationalizing device formularies and care bundles, making collaborative value demonstration and interoperability with standard surgical platforms decisive for market penetration.

A comprehensive assessment of how anticipated 2025 tariff shifts will affect procurement, supply chain resilience, and strategic sourcing for hernia repair stakeholders

Anticipated tariff adjustments in the United States in 2025 introduce a layer of complexity to procurement strategies and global supply chain planning for hernia repair devices. Tariff dynamics can influence cost structures for imported materials and finished implants, and they therefore affect sourcing decisions, inventory strategies, and commercial pricing. Organizations that manage cross-border supplier relationships must reassess contractual terms, logistics routing, and duty mitigation strategies to preserve competitiveness.

In response to tariff-driven cost pressures, manufacturers and healthcare systems may re-evaluate localization of production, increase emphasis on regional supplier diversification, and refine total landed cost models rather than relying on unit price alone. Such adjustments can accelerate trends toward nearshoring or strategic stockpiling of critical components, while also prompting more rigorous supplier performance analytics to identify resilience gaps.

Clinically, tariff-related cost shifts could influence hospital procurement committees' device selection criteria and negotiations with vendors, particularly where alternative materials or domestic suppliers offer comparable clinical performance. Importantly, the cumulative impact of tariffs is not limited to price alone; it also affects timelines for technology transfer, regulatory submissions tied to manufacturing changes, and long-term partnerships. Organizations that proactively model tariff scenarios and integrate them into commercial and operational planning will mitigate disruption and preserve strategic flexibility.

A deep segmentation-driven perspective linking material classes, procedural subtypes, anatomical indications, and care settings to inform tailored clinical and commercial strategies

Segmentation insight is essential to understand how distinct product characteristics, procedural approaches, hernia types, and care settings intersect to shape clinical decision-making and commercial strategy. When considering product type, analyses must differentiate between Biological Mesh and Synthetic Mesh; the Biological Mesh category further divides into animal-derived and human-derived constructs, while Synthetic Mesh encompasses polyester, polypropylene, and polytetrafluoroethylene variants, each presenting unique handling, integration, and infection-resistance profiles. These material distinctions influence surgeon preference, sterilization protocols, and postoperative management expectations.

Procedure type segmentation distinguishes laparoscopic from open approaches, with laparoscopic techniques further classified into total extraperitoneal and transabdominal preperitoneal methods. Device design and delivery systems need to align with these procedural subtypes to ensure compatibility with trocar sizes, fixation strategies, and visualization workflows. Meanwhile, hernia type segmentation across hiatal, incisional, inguinal, umbilical, and ventral presentations underscores the need for tailored implant geometries, fixation options, and perioperative care pathways that reflect anatomical and biomechanical variations.

End user segmentation divides the landscape among ambulatory surgical centers, clinics, and hospitals, each with different procurement cycles, case mixes, and facility resources. Ambulatory centers prioritize fast turnover and simplified supply chains, clinics may focus on outpatient continuity of care, and hospitals must balance complex, high-acuity cases with broader procurement governance. Integrating these segmentation lenses enables targeted product positioning, evidence generation plans, and commercialization tactics that resonate with the specific operational realities of each buyer type.

A nuanced regional analysis that aligns divergent clinical practices, regulatory regimes, and supply chain realities across the Americas, EMEA, and Asia-Pacific to guide market entry and scale plans

Regional dynamics exert substantial influence over clinical practice patterns, regulatory expectations, and supply chain architectures, creating distinct strategic considerations across geographies. In the Americas, healthcare delivery emphasizes both large academic centers and an expanding network of ambulatory surgical settings, which together create demand for devices that balance advanced clinical performance with operational efficiency; reimbursement models and public-private payer mixes also shape procurement priorities and evidence requirements.

Across Europe, the Middle East & Africa, regulatory diversity and heterogeneous payer landscapes necessitate flexible market entry strategies and adaptable clinical data packages. Device acceptance here often hinges on regional clinical opinion leaders and country-specific health technology assessment processes, making phased rollouts and local investigator-led studies valuable. In the Asia-Pacific region, rapid infrastructure development, increasing access to minimally invasive surgery, and variable domestic manufacturing capacity create opportunities for both innovative importers and locally based producers; procurement decisions frequently reflect a mix of cost sensitivity and a rising emphasis on clinical outcomes.

Taken together, these regional differences require manufacturers to tailor regulatory strategies, distribution partnerships, and clinical engagement plans. Strategic localization of evidence generation, targeted training programs for surgeons across differing procedural norms, and supply chain arrangements that reflect regional logistics realities will be decisive for commercial success.

A strategic synthesis of competitive forces, innovation focus areas, and partnership models that are redefining differentiation and value capture in hernia repair markets

Competitive dynamics in the hernia repair space reflect a balance between established surgical supply leaders and emerging innovators in biomaterials and fixation technologies. Leading firms continue to invest in iterative improvements to polymer and biologic scaffolds, enhanced delivery systems for minimally invasive procedures, and evidence generation that supports value-based procurement conversations. Meanwhile, smaller specialized players focus on disruptive material chemistries, surface modifications, and adjunct technologies such as antimicrobial coatings and absorbable fixation devices.

Partnerships between device manufacturers and clinical centers of excellence have become instrumental in accelerating adoption by demonstrating procedural efficiencies and patient-centric outcomes. Strategic collaborations with contract manufacturers and regional distributors further enable scale while managing cost structures. Intellectual property around material science and proprietary manufacturing processes remains a critical differentiator, as does the ability to integrate post-market surveillance and registries that document long-term performance.

As adoption criteria shift toward holistic value, companies that can present robust clinical evidence, streamlined logistics, and compelling surgeon training programs will maintain competitive advantage. Organizations should also monitor emerging entrants that leverage digital health adjuncts, such as surgical planning tools or analytics platforms, which can complement device offerings and create integrated value propositions for hospital systems and ambulatory centers alike.

Actionable, implementation-focused recommendations for leaders to align R&D, supply chain, and commercial models with clinical outcomes and payer expectations in hernia repair

Industry leaders can take decisive actions to convert emerging trends into sustainable advantages by aligning R&D, commercial, and operational priorities with clinical and payer demands. First, prioritize investment in materials and delivery systems that demonstrably improve integration, reduce infection risk, and simplify implantation for both open and laparoscopic techniques, supported by pragmatic clinical endpoints and real-world evidence collection initiatives. Second, establish cross-functional evidence-generation roadmaps that incorporate surgeon-led registries and post-market surveillance to satisfy regulators and purchasers while shortening the feedback loop for iterative product improvements.

Operationally, strengthen supply chain resilience by diversifying sources for critical inputs and exploring regional manufacturing options to mitigate tariff and logistics exposure. Cultivate robust training and proctoring programs tailored to ambulatory surgical center workflows and hospital operating suites, thereby reducing variation in clinical outcomes and accelerating institutional adoption. Finally, pursue value-driven commercial models that align pricing and reimbursement approaches with demonstrable clinical benefits and total episode-of-care efficiencies.

By executing these strategic moves, leaders will be positioned to navigate regulatory complexity, meet evolving clinical expectations, and secure durable partnerships with providers and payers. These recommendations emphasize practical implementation pathways that balance near-term operational resilience with long-term innovation-led differentiation.

A transparent, mixed-methods research design combining clinician insights, regulatory and clinical literature review, and supply chain scenario analysis to validate conclusions and recommendations

The research underpinning this executive synthesis integrates a structured combination of primary and secondary information-gathering methods designed to ensure analytical rigor and practical relevance. Primary inputs included structured interviews with clinical specialists across general and minimally invasive surgery, procurement leaders from ambulatory, clinic, and hospital settings, and subject-matter experts in biomaterials and regulatory affairs. These qualitative discussions informed hypothesis generation and prioritized areas for deeper analysis.

Secondary research encompassed peer-reviewed clinical literature, regulatory filings, device labeling information, and publicly available health policy documents to frame clinical performance attributes and regulatory trends. Comparative device characteristics and procedural technique literature were triangulated with real-world practice insights to validate clinical relevance. Supply chain and tariff scenario analysis relied on trade data, logistics expert commentary, and scenario planning methodologies to assess operational implications under different assumptions.

Analytical approaches combined thematic synthesis from qualitative interviews with cross-sectional comparative analyses of device attributes and care pathways. Quality assurance steps included cross-validation of key findings with multiple clinical sources and a review by external advisors to ensure objectivity. This mixed-methods approach supports actionable conclusions while maintaining methodological transparency and traceability.

A conclusive synthesis emphasizing the imperative to combine clinical evidence, operational resilience, and tailored commercialization to realize improved outcomes and sustainable value

In summary, the hernia repair field is at an inflection point driven by material innovation, procedural evolution toward minimally invasive care, and shifting procurement dynamics influenced by regional considerations and trade policy changes. Stakeholders who integrate rigorous clinical evidence generation with pragmatic supply chain and commercialization strategies will secure strategic advantages in a competitive landscape where clinical differentiation and operational efficiency matter equally.

Decision-makers should view device selection and partnership choices through a multidimensional lens that accounts for product attributes, procedural compatibility, patient outcomes, and care setting constraints. Regulatory and reimbursement dynamics necessitate an emphasis on demonstrable value, while tariff and supply chain considerations underscore the importance of operational resilience. Ultimately, organizations that align clinical innovation with real-world implementation plans-supported by targeted evidence and strong clinical partnerships-will be best positioned to deliver improved patient outcomes and sustainable commercial performance.

This report offers a foundation for such alignment and serves as a practical reference for clinical, commercial, and operational leaders seeking to translate insight into effective action within the evolving hernia repair landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia Repair Market, by Product Type

  • 8.1. Biological Mesh
    • 8.1.1. Animal
    • 8.1.2. Human
  • 8.2. Synthetic Mesh
    • 8.2.1. Polyester
    • 8.2.2. Polypropylene
    • 8.2.3. Polytetrafluoroethylene

9. Hernia Repair Market, by Procedure Type

  • 9.1. Laparoscopic
    • 9.1.1. Total Extraperitoneal
    • 9.1.2. Transabdominal Preperitoneal
  • 9.2. Open

10. Hernia Repair Market, by Hernia Type

  • 10.1. Hiatal
  • 10.2. Incisional
  • 10.3. Inguinal
  • 10.4. Umbilical
  • 10.5. Ventral

11. Hernia Repair Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Hernia Repair Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hernia Repair Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hernia Repair Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hernia Repair Market

16. China Hernia Repair Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AbbVie Inc.
  • 17.6. Aran Biomedical by Integer Holdings Corporation
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Becton, Dickinson and Company
  • 17.10. Betatech Medical
  • 17.11. BioCer Entwicklungs-GmbH
  • 17.12. Boston Scientific Corporation
  • 17.13. Coloplast A/S
  • 17.14. CooperSurgical, Inc.
  • 17.15. Cousin Surgery
  • 17.16. Deep Blue Medical Advances, Inc.
  • 17.17. Dolphin Sutures
  • 17.18. Getinge AB
  • 17.19. HERNIAMESH S.r.l.
  • 17.20. Hwainmedi Co., Ltd.
  • 17.21. Insightra Medical Inc.
  • 17.22. Integra LifeSciences Holdings Corporation
  • 17.23. Intuitive Surgical, Inc.
  • 17.24. Johnson & Johnson Services, Inc.
  • 17.25. KATSAN Katgut Sanayi ve Tic. A.S.
  • 17.26. Medtronic PLC
  • 17.27. Meril Life Sciences Pvt. Ltd.
  • 17.28. Momentis Surgical Ltd.
  • 17.29. Novus Scientific AB
  • 17.30. Olympus Corporation
  • 17.31. Secant Group, LLC
  • 17.32. Surgimatix, Inc.
  • 17.33. TELA Bio, Inc.
  • 17.34. W. L. Gore & Associates, Inc.
  • 17.35. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA REPAIR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA REPAIR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA REPAIR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA REPAIR MARKET SIZE, BY ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA REPAIR MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA REPAIR MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA REPAIR MARKET SIZE, BY TOTAL EXTRAPERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA REPAIR MARKET SIZE, BY TRANSABDOMINAL PREPERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA REPAIR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA REPAIR MARKET SIZE, BY HIATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA REPAIR MARKET SIZE, BY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA REPAIR MARKET SIZE, BY INGUINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA REPAIR MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA REPAIR MARKET SIZE, BY VENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERNIA REPAIR MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERNIA REPAIR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HERNIA REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 143. GCC HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 144. GCC HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 146. GCC HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 167. G7 HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 168. G7 HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 170. G7 HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 175. NATO HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 176. NATO HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 178. NATO HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA HERNIA REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA HERNIA REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA HERNIA REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA HERNIA REPAIR MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA HERNIA REPAIR MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA HERNIA REPAIR MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA HERNIA REPAIR MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA HERNIA REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)